We have a bold goal – we are working towards changing the future of medicine. Here at Athersys, we have established a portfolio of therapeutic product development programs to address significant unmet medical need in several disease areas that are also substantial commercial opportunities. Together, we are committed to the discovery and development of best-in-class therapies designed to extend and enhance the quality of human life with our advancing clinical pipeline. We value our shareholders and thank you for being a part of our mission to change the future of medicine.
Learn More
Quiet Period
We are committed to SEC policies regarding fair disclosure. Our company observes a two week quiet period prior to each quarter’s earnings release during which time we generally do not answer investor related questions or discuss new information. If you have an urgent inquiry, please contact [email protected] and we can respond if appropriate.